Price:
Rs. 7,365.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: D0026
Frequently Asked Questions (FAQ's):
What does the DMD/BMD (18 Exons) test include?
This test screens the 18 critical exons of the dystrophin gene to identify deletions or mutations causing DMD and BMD.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated molecular methods, such as multiplex PCR or MLPA, to detect mutations in the dystrophin gene accurately.
Who should take this test?
Patients with clinical suspicion of DMD/BMD, family members for carrier testing, or prenatal evaluation may be advised to take this test.
What sample type is required?
An EDTA anticoagulated blood sample is required for high-quality DNA extraction and precise analysis.
Why is this test important?
Detecting dystrophin gene mutations helps confirm diagnosis, guide prognosis, inform treatment strategies, and support genetic counseling.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows strict quality control, validated molecular protocols, and expert interpretation to ensure accurate and reproducible results.
Is any preparation needed before the test?
No special preparation or fasting is required; patients should follow physician instructions for sample collection.
How soon are results available?
Turnaround time may vary depending on test complexity, but Metropolis Healthcare provides timely and comprehensive reports to support clinical and genetic decision-making.